Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes - ESMO | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ESMO
2022
·
Europe
·
Oncology
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes
Document
Analyser ce document
